Events
18 November 2022
Our portfolio of #GPCR#fluorescent ligands is growingWe have just added to our catalogue two more fluorescent ligands for the α1-Adrenergic receptor, CELT-130 and CELT-133. α1-Adrenergic receptors play a vital role in the regulation of […]
9 November 2022
The XIV meeting of the Spanish Drug Discovery Network (SDDN) will take place in Granada, Spain, on November 24 and 25, 2022. This international conference has […]
7 November 2022
Cannabinoid receptors, CB1 and CB2 are two extensively studied targets of the GPCR family for the treatment of numerous conditions, including inflammatory diseases, autoimmune disorders, pain, […]
26 October 2022
G-protein coupled receptors (GPCRs) have been targeted mainly in a wide range of diseases. Still, few therapies have been directed against GPCRs in the field of cancer, […]
20 September 2022
To date, it has been reported that about 800 GPCRs are encoded by the human genome. Some of them have known ligands available which led to the […]
21 February 2022
From February 5th to 9th our CEO Sonia Martínez Arca has attended the international SLAS, (Society for Laboratory Automation and Screening), meeting at Boston. Celtarys Research […]
24 November 2021
Farmaforum has become one of the most important events of the pharmaceutical industry in Spain. In the 2021 edition, it has extended its scope, sharing synergies […]
4 October 2021
ELRIG’s annual Drug Discovery meeting is still Europe’s largest meeting for life sciences industry professionals and will return on 19th and 20th of October 2021, to […]
31 August 2021
BIOSPAIN, the international meeting focused on biotechnology, is just around the corner and our BD Team will be present in the event. With more than 3,000 […]